Publications by authors named "M A Schoen"
Assessment of comorbid diseases is essential to clinical research and may risk-stratify patients for mortality independent of established methods such as the Charlson Comorbidity Index (CCI). In a retrospective study of U.S.
View Article and Find Full Text PDFArticle Synopsis
- Socioeconomic deprivation negatively affects access to timely surgical care and quality measures for early-stage non-small cell lung cancer (NSCLC) among Veterans in the Veterans Health Administration (VHA).
- A study analyzed 9,704 Veterans with stage I NSCLC, revealing that those from areas of high socioeconomic deprivation were less likely to receive essential preoperative evaluations and timely surgery compared to those from less deprived areas.
- Post-surgery, Veterans in high deprivation areas had a higher risk of 30-day hospital readmission and were less likely to meet recommended care quality standards than their counterparts with lower deprivation levels.
Article Synopsis
- - Prostate cancer is the second leading cause of death in American men, but early detection and treatment can be curative; advanced stages like mCRPC pose significant mortality risks.
- - This study examined how different medications (abiraterone and enzalutamide) affect the survival duration of patients with mCRPC, using machine learning to analyze patient demographics and health data.
- - Findings revealed that veterans treated with enzalutamide had an average increase of approximately 60 days in survival compared to those treated with abiraterone, highlighting the potential for tailored treatment strategies.
Background: Currently, there is no consensus on how to comprehensively assess comorbidities in lung cancer patients in the clinical setting. Prescription medications may be a preferred comorbidity assessment tool and provide a simple mechanism for predicting postoperative outcomes for lung cancer. We examined the relationship between prescription medications and postoperative outcomes for early-stage non-small cell lung cancer (NSCLC).
View Article and Find Full Text PDF